Disease Treatment
Disease Treatment - Related Videos
01:24
Parkinson's Disease: Treatment
0 Views •
2024
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury. Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:22
Alzheimer's Disease: Treatment
0 Views •
2024
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
01:32
Evoked Gamma Oscillations for the Treatment of Alzheimer’s Disease
0 Views •
2025
Begin with a patient diagnosed with Alzheimer’s disease, wearing a gamma therapy stimulation device.The device consists of an eye-set and headphones.Using the controller, activate the device to deliver auditory and visual stimulation.The visual component emits flickering light at a gamma frequency, while the auditory component produces synchronized sound pulses.Gamma oscillations are brain waves generated by synchronized neuronal firing, crucial for cognition and memory.In AD, these...
04:24
Acupoint Application as a Traditional Chinese Medicine Treatment for Fatigue Associated with Chronic Obstructive Pulmonary Disease
0 Views •
2025
This protocol describes the specific process and efficacy of acupoint application in treating fatigue symptoms associated with chronic obstructive pulmonary disease.
01:21
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
0 Views •
2024
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2 (COX-2),...
FAQs
Engineering-oriented treatment design starts by connecting a disease mechanism to a measurable target. This target gives developers a defined basis for selecting an intervention and judging whether it modifies the relevant biological problem. The target may represent a process that needs control or a function that needs support, helping translate biological understanding into an engineered therapeutic strategy.
Devices, biomaterials, drug-delivery systems, and engineered tissues provide different platforms for modifying disease-related targets or supporting damaged organs. Their value lies in linking physical design with biological requirements. Depending on the treatment goal, an engineered system can help deliver an intervention, regulate its behavior, replace lost function, or provide structural support within a broader therapeutic strategy.
Precision depends not only on what treatment is delivered, but also on how much is delivered and when it acts. Engineered drug-delivery systems can help regulate dose and timing, allowing treatment design to match the targeted disease process more closely. Better control may improve therapeutic precision, support safer therapies, and reduce harm associated with treatment.
A treatment-development workflow can begin by identifying the disease mechanism, translating it into a measurable target, and selecting an engineered approach that can modify that target or support impaired function. Biology guides the therapeutic objective, while materials science, mechanics, and computation shape the design. This combined process helps produce interventions suited to complex biological problems.
Several technologies may be combined when a disease requires both targeted intervention and support for damaged function. A design might draw on a device, biomaterial, drug-delivery system, or engineered tissue according to the identified target and therapeutic need. Combining these areas allows treatment developers to address biological mechanisms, physical requirements, dose control, and functional restoration within one coordinated approach.
Computation contributes by helping integrate the biological and engineering considerations used to design treatment strategies. In the context of complex diseases, this supports development of personalized solutions rather than relying on a single uniform design. Its role complements materials science, mechanics, and biological analysis, helping align engineered interventions with measurable targets and individual therapeutic requirements.
Engineering provides a framework for connecting disease biology with controllable therapeutic systems. By combining biological knowledge with materials science, mechanics, and computation, researchers can design devices, delivery systems, biomaterials, or engineered tissues that improve precision and support damaged organs. These capabilities are relevant to complex diseases because they can promote safer therapies, restore function, and improve health outcomes.